M6A-Related Bioinformatics Analysis Reveals a New Prognostic Risk Signature in Cutaneous Malignant Melanoma

Figure 4

The prognosis analysis and validation in the GEO database of the three selected m6A RNA methylation regulators. (a) The ROC curve showed the predictive efficiency of the risk signature on CMM. (b) OBS survival curve of CMM patients based on the three selected m6A RNA methylation regulators levels in the TCGA dataset. (c) The validation of prognosis efficiency of the three selected m6A RNA methylation regulators using the GEO database (GSE65904).

(a)

(b)

(c)